Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Posts Flat Q4 Revenue and R&D Spend as Profit Tumbles 31 Percent

NEW YORK (GenomeWeb News) — Molecular Devices today said fourth-quarter revenues remained virtually flat as R&D spending was unchanged and profit decreased 31 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $52.8 million from $52.7 million year over year.
 
Molecular Devices did not break out revenues by business unit.
 
R&D spending was flat at $6.3 million in both quarters.
 
The company said profit declined to $4 million from $5.8 million in the year-ago period.
 
Molecular Devices said it had around $22.8 million in cash and equivalents as of Dec. 31.
 
Last week MDS said it plans to acquire Molecular Devices for $615 million in cash.